[HTML][HTML] Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective …

B Lettner, K Mason, ZR Greenwald, J Broad… - The Lancet Regional …, 2023 - thelancet.com
Background Despite high burden of Hepatitis C (HCV) among people who inject drugs,
significant barriers to care persist. The aim of this study was to evaluate the provision of …

Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically …

MB MacIsaac, B Whitton, J Anderson, S Cogger… - International Journal of …, 2024 - Elsevier
Background To achieve hepatitis C virus (HCV) elimination targets, simplified care engaging
people who inject drugs is required. We evaluated whether fingerstick HCV RNA point-of …

[HTML][HTML] Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led …

J Grebely, R Gilliver, T McNaughton, A Conway… - International Journal of …, 2023 - Elsevier
Background Point-of-care hepatitis C virus (HCV) RNA testing can facilitate single-visit
diagnosis and treatment. This study evaluated a single-visit test and treat intervention …

The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination

SN Kapadia, AE Jordan, BJ Eckhardt… - Clinical Infectious …, 2024 - academic.oup.com
Hepatitis C virus (HCV) elimination is an important global public health goal. However, the
United States is not on track to meet the World Health Organization's 2030 targets for HCV …

[HTML][HTML] Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and …

A Trickey, E Fajardo, D Alemu, AA Artenie… - The lancet …, 2023 - thelancet.com
Background Point-of-care (POC) hepatitis C virus (HCV) RNA nucleic acid test viral load
assays are being used increasingly as an alternative to centralised, laboratory-based …

Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross‐sectional analysis

ZR Greenwald, Z Bouck, E McLean… - Journal of viral …, 2023 - Wiley Online Library
Despite the availability of publicly funded hepatitis C (HCV) treatment in Canada, treatment
gaps persist, particularly among people who inject drugs. We estimate correlates of HCV …

A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

J Grebely, C Markus, LM Causer, D Silk… - The Lancet …, 2023 - thelancet.com
Comment www. thelancet. com/gastrohep Vol 8 March 2023 205 is hampered by current
diagnostic pathways requiring several visits and frequent loss to follow-up, amplified in key …

The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An …

J Howell, MW Traeger, B Williams… - Journal of viral …, 2022 - Wiley Online Library
Abstract Point‐of‐care (POC) diagnostics overcome barriers to conventional hepatitis C
(HCV) testing in people who inject drugs. This study assessed impact on hepatitis C …

Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening

V Koo, F Tian, WWL Wong - Liver International, 2022 - Wiley Online Library
Abstract Background & Aims Hepatitis C virus (HCV) continues to pose significant public
health concerns with approximately 44% of chronically infected Canadians undiagnosed …

[HTML][HTML] Hepatitis C point-of-care screening in retail pharmacies in the United States

M Kugelmas, LD Pedicone, I Lio, S Simon… - Gastroenterology & …, 2017 - ncbi.nlm.nih.gov
Abstract Background and Aims: Approximately half of adults with hepatitis C in the United
States do not know their infection status, and the majority of persons who know they are …